Literature DB >> 1749305

Inflammation amplifies the antitumor cytostasis by human peritoneal macrophages.

S Ben-Efraim1, C Tak, M J Fieren, G J Van den Bemd, I L Bonta.   

Abstract

The effect of an inflammatory environment on the antitumor cytostatic ability of human macrophages was examined. Peritoneal macrophages of patients on continuous ambulatory peritoneal dialysis (CAPD) were collected, when CAPD was without complication, during an intercurrent infectious inflammation and after recovery. Inhibition of 3H-thymidine uptake served as a measure of cytostasis by macrophages co-cultured with target murine cells MOPC-315 plasmacytoma, WEHI-3B myelomonocytic leukemia and L929 transformed fibroblasts. Macrophages from inflammatory peritoneum expressed a markedly enhanced cytostasis, irrespective of the nature of the tumor cell. Endotoxin (LPS) challenge of inflammatory macrophages failed to further reinforce the cytostasis towards MOPC-315 plasmacytoma, but reinforced the cytostasis towards WEHI-3B leukemia (sensitive to inhibition by IL-1) and towards L929 (sensitive to TNF alpha). Cytostasis by supernatants of human peritoneal macrophages against L929 was markedly inhibited by anti-rHuTNF alpha and against WEHI-3B by anti-rHuIL-1 beta. The results suggest a link between inflammatory function and antitumor cytostasis by macrophages. This link is constituted by mediators involved in the activation process of macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1749305     DOI: 10.1007/bf02988859

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  17 in total

1.  Development of antitumor activity in LPS-stimulated mouse granuloma macrophages. Regulation by eicosanoids.

Authors:  J C Drapier; J F Petit
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

2.  The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms.

Authors:  J L Humes; S Burger; M Galavage; F A Kuehl; P D Wightman; M E Dahlgren; P Davies; R J Bonney
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

3.  Infectious-inflammatory changes in cyclic AMP levels and in their regulation by prostaglandins in human peritoneal macrophages.

Authors:  M J Adolfs; M W Fieren; I L Bonta
Journal:  Prostaglandins Leukot Med       Date:  1985-05

4.  Macrophage cytokines render WEHI-3B tumor cells susceptible to cytostasis by prostaglandins.

Authors:  S Ben-Efraim; C Tak; I L Bonta
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1990-06       Impact factor: 4.006

5.  Prostaglandin E2 enhances, and leukotriene C4 inhibits, interleukin-1 inhibition of WEHI-3B cell growth.

Authors:  G R Elliott; C Tak; I L Bonta
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor.

Authors:  G R Elliott; C Tak; C Pellens; S Ben-Efraim; I L Bonta
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  A routine source of human peritoneal macrophages.

Authors:  Y Maddox; M Foegh; B Zeligs; M Zmudka; J Bellanti; P Ramwell
Journal:  Scand J Immunol       Date:  1984-01       Impact factor: 3.487

8.  Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.

Authors:  R Ophir; S Ben-Efraim; I L Bonta
Journal:  Int J Tissue React       Date:  1987

9.  Specific lipoxygenase inhibition reverses macrophage cytotasis towards P815 tumor cells in vitro induced by the calcium ionophore A23187.

Authors:  J A Van Hilten; G R Elliott; I L Bonta
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1988-12       Impact factor: 4.006

10.  Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humans.

Authors:  I L Bonta; M J Adolfs; M W Fieren
Journal:  Int J Immunopharmacol       Date:  1984
View more
  2 in total

1.  Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice.

Authors:  S Ben-Efraim; C Tak; J C Romijn; M J Fieren; I L Bonta
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

2.  Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.